TCIM
AVNS

TIAA CREF Investment Management’s Avanos Medical AVNS Stock Holding History

TIAA CREF Investment Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.93M Sell
92,178
-1,444
-2% -$64.7K ﹤0.01% 1595
2018
Q4 		$4.19M Sell
93,622
-3,623
-4% -$190K ﹤0.01% 1490
2018
Q3 		$6.66M Sell
97,245
-7,978
-8% -$513K ﹤0.01% 1379
2018
Q2 		$6.02M Sell
105,223
-10,196
-9% -$539K ﹤0.01% 1471
2018
Q1 		$5.32M Sell
115,419
-92,595
-45% -$4.4M ﹤0.01% 1517
2017
Q4 		$9.61M Sell
208,014
-26,570
-11% -$1.22M 0.01% 1166
2017
Q3 		$10.6M Buy
234,584
+31,683
+16% +$1.35M 0.01% 1118
2017
Q2 		$7.97M Buy
202,901
+52,881
+35% +$2M 0.01% 1284
2017
Q1 		$5.71M Sell
150,020
-7,020
-4% -$274K ﹤0.01% 1510
2016
Q4 		$5.81M Sell
157,040
-12,498
-7% -$447K ﹤0.01% 1498
2016
Q3 		$5.88K Buy
169,538
+1,161
+0.7% +$40.7K ﹤0.01% 1495
2016
Q2 		$5.48M Buy
168,377
+18,610
+12% +$570K ﹤0.01% 1479
2016
Q1 		$4.3M Sell
149,767
-685
-0.5% -$18.3K ﹤0.01% 1602
2015
Q4 		$5.03M Sell
150,452
-4,232
-3% -$132K ﹤0.01% 1552
2015
Q3 		$4.4M Buy
154,684
+28,151
+22% +$982K ﹤0.01% 1622
2015
Q2 		$5.13M Sell
126,533
-81,067
-39% -$3.64M ﹤0.01% 1669
2015
Q1 		$10.2M Buy
207,600
+51,685
+33% +$2.39M 0.01% 1126
2014
Q4 		$7.09M Buy
+155,915
New +$6.13M 0.01% 1376

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TIAA CREF Investment Management's AVNS Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Avanos Medical (AVNS) stake by 1.5% in Q1 2019, selling an estimated $64.7K and leaving 92,178 shares worth $3.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

TIAA CREF Investment Management first reported a position in AVNS in Q4 2014 and has held it in 18 quarters since. The position peaked at $10.6M in Q3 2017. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

  • TIAA CREF Investment Management held 92,178 shares of Avanos Medical worth $3.93M as of Q1 2019.
  • TIAA CREF Investment Management sold 1,444 Avanos Medical shares in Q1 2019, an estimated $64.7K.
  • Avanos Medical made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1595 holding.
  • TIAA CREF Investment Management first reported a position in Avanos Medical in Q4 2014 and has held it in 18 quarters since.
  • TIAA CREF Investment Management's Avanos Medical position peaked at $10.6M in Q3 2017.
  • 338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.